Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stoke Therapeutics Inc (STOK)

Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Stoke Therapeutics Inc 45 WIGGINS AVENUE BEDFORD MA 01730 USA

www.stoketherapeutics.com Employees: 110 P: 781-430-8200

Description:

Stoke Therapeutics Inc. is a biopharmaceutical company. It develops antisense oligonucleotide medicines to treat genetic diseases. The company's product candidate consists of STK-001 which is to treat Dravet syndrome, a severe and progressive genetic epilepsy. Stoke Therapeutics Inc. is based in Bedford, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 599,586
Enterprise Value, $K 408,146
Shares Outstanding, K 52,967
Annual Sales, $ 8,780 K
Annual Net Income, $ -104,700 K
Last Quarter Sales, $ 4,890 K
Last Quarter Net Income, $ -26,430 K
EBIT, $ -117,300 K
EBITDA, $ -115,160 K
60-Month Beta 0.95
% of Insider Shareholders 11.30%
Float, K 46,982
% Float 88.70%
Short Volume Ratio 0.69

Growth:

1-Year Return 112.38%
3-Year Return -52.81%
5-Year Return -54.76%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.47 on 11/05/24
Next Earnings Date N/A
Earnings Per Share ttm -2.10
EPS Growth vs. Prev Qtr -2.17%
EPS Growth vs. Prev Year 14.55%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

STOK Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.45%
Return-on-Assets % -40.77%
Profit Margin % -1,192.48%
Debt/Equity 0.00
Price/Sales 70.04
Price/Cash Flow N/A
Price/Book 2.63
Book Value/Share 4.41
Interest Coverage -1.53
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar